Global melanoma cancer market: global market size, industry growth, f bladder cancer MARKET | Page 2

Global melanoma cancer market: global market size, industry growth, future
prospects, opportunities and forecast 2018-2023
Orion Market Research (OMR) recently published a market research report on global bladder cancer. It
is estimated that the market is augmenting with a notable growth rate during the forecast period 2018-
2023. The market is augmenting due to increasing incidence of bladder cancer globally and high
prevalence of bladder cancer in the geriatric population. The geriatric population is also growing
significantly globally. The global bladder cancer is segmented on the basis of cancer type, therapy and by
diagnosis method. The report provides detailed and insightful chapters which include market overview,
key findings, strategic recommendations, market estimations, market determinants, key company
analysis, competitive landscape, company profiling, market segmentation, geographical analysis, and
analyst insights of the market.
Browse Full Report At: https://www.omrglobal.com/industry-reports/bladder-cancer-market/
A bladder is a hollow, balloon-shaped organ of the urinary system. Its cancer is a tumor which starts in
the cells of the bladder. Generally, bladder cancer starts in cells of the urothelium. When the cancer is
only in the urothelium, it is called non-invasive bladder cancer. When cancer spreads into the connective
tissue or muscle in the wall of the bladder, it is known as invasive bladder cancer. As per the American
Medical Association, the total incident cases of the bladder cancer in 2015 were more than 540,000 with
a growth of 31% as compared to 2005 globally. Out of this, total mortality registered due to bladder
cancer is 188,000 globally. Bladder cancer is the ninth leading cause of mortality due to different types
of cancer globally in 2015. It is the 5th leading cause of death in Italy, Spain, and Poland due to different
types of cancer. It occurs mainly in older people. About 90% of people with this cancer are over the age
of 55. The average age at the time of diagnosis is 73 in the US.
Large geriatric population is another major factor in augmenting the bladder cancer cases and their
overall market globally. Factor for the high prevalence of bladder cancer to an elderly person is the
prolonged exposure to hazards over the course of one's lifetime. The consumption of cigarette, aromatic
amines, and others harmful substances results into body inability to clear toxins secondary to organ
system deterioration. Additionally, a decline in bladder function is believed to increase the exposure